S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Critical asset just had biggest fall on record (Ad)
This healthcare stock making a buzz with 160% growth
How major US stock indexes fared Monday, 2/26/2024
Critical asset just had biggest fall on record (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
Domino’s stock or Papa John’s? Follow price action to find out
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Critical asset just had biggest fall on record (Ad)
This healthcare stock making a buzz with 160% growth
How major US stock indexes fared Monday, 2/26/2024
Critical asset just had biggest fall on record (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
Domino’s stock or Papa John’s? Follow price action to find out
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Critical asset just had biggest fall on record (Ad)
This healthcare stock making a buzz with 160% growth
How major US stock indexes fared Monday, 2/26/2024
Critical asset just had biggest fall on record (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
Domino’s stock or Papa John’s? Follow price action to find out
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Critical asset just had biggest fall on record (Ad)
This healthcare stock making a buzz with 160% growth
How major US stock indexes fared Monday, 2/26/2024
Critical asset just had biggest fall on record (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
Domino’s stock or Papa John’s? Follow price action to find out

Landos Biopharma (LABP) Earnings Date, Estimates & Call Transcripts

$6.24
-0.05 (-0.79%)
(As of 02/26/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

LABP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LABP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Landos Biopharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($1.12)($1.12)($1.12)
Q2 20241($1.12)($1.12)($1.12)
Q3 20241($1.12)($1.12)($1.12)
Q4 20241($0.33)($0.33)($0.33)
FY 20244($3.69)($3.69)($3.69)

LABP Earnings Date and Information

Landos Biopharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 28th, 2024 based off prior year's report dates.

Landos Biopharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/28/2024
Estimated)
------- 
11/9/2023Q3 2023($0.79)($0.94)($0.15)($0.94)--
8/9/2023Q2 2023($1.10)($0.63)+$0.47($0.63)--
5/12/2023Q1 2023($1.00)($0.90)+$0.10($0.09)--
3/23/2023Q4 2022($1.50)($1.30)+$0.20($0.13)--
11/10/2022Q3 2022($2.90)($2.00)+$0.90($0.20)--
8/11/2022Q2 2022($3.70)($2.80)+$0.90($0.28)--
5/12/2022Q1 2022($3.70)($3.70)-($0.37)--    
3/24/2022Q4 2021($3.00)($5.20)($2.20)($0.52)--
11/15/2021Q3 2021($4.40)($3.20)+$1.20($0.32)--    
7/28/2021Q2 2021($1.40)$1.20+$2.60$0.12$18.00 million$18.00 million
5/16/2021Q1($3.75)($3.80)($0.05)($0.38)--












Landos Biopharma Earnings - Frequently Asked Questions

When is Landos Biopharma's earnings date?

Landos Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 28th, 2024 based off last year's report dates. Learn more on LABP's earnings history.

How much revenue does Landos Biopharma generate each year?

Landos Biopharma (NASDAQ:LABP) has a recorded annual revenue of $18 million.

How much profit does Landos Biopharma generate each year?

Landos Biopharma (NASDAQ:LABP) has a recorded net income of -$39.28 million. LABP has generated -$3.77 earnings per share over the last four quarters.

What is Landos Biopharma's EPS forecast for next year?

Landos Biopharma's earnings are expected to grow from ($3.41) per share to ($2.03) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:LABP) was last updated on 2/27/2024 by MarketBeat.com Staff